Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
Texas AG Investigates Lululemon Over "Forever Chemicals" in Activewear 
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO 
ASML Raises 2026 Revenue Outlook as AI Chip Demand Surges 
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production 
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit 
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
Anthropic Nears $800 Billion Valuation as Investor Confidence Surges 
SK Hynix Shares Hit Record High Amid AI Memory Demand Surge 
Amazon in Advanced Talks to Acquire Globalstar in Starlink Rivalry Move 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
NEW YORK, April 04, 2016 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased DS Healthcare Group, Inc. (NASDAQ:DSKX) securities between August 13, 2015 and March 23, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/ds-healthcare-group. There is no cost or obligation to you.
On March 23, 2016, DS Healthcare revealed that its financial statements for the two fiscal quarters ended June 30, 2015 and September 30, 2015 were found to have revenue recognition errors and improper recording of certain equity. The Company also announced that the Audit Committee and independent counsel had initiated an investigation in connection with the company’s President, Daniel Khesin, for allegedly fraudulent revenue recognition and equity transaction errors, and that Mr. Khesin had been dismissed. Then on March 28, 2016, the Company announced that the Audit Committee determined the errors totaled approximately $900,000 in reduced revenues, and that as a result, estimated unaudited 2015 fiscal year revenues should be reduced by approximately 6 percent.
If you suffered a loss in DS Healthcare you have until May 31, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/ds-healthcare-group.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
